Printer Friendly

WARNER-LAMBERT ESTABLISHES HOTLINE TO ANSWER CONSUMER, PHYSICIAN QUESTIONS ABOUT OTC ALLERGY MEDICATIONS

 WARNER-LAMBERT ESTABLISHES HOTLINE TO ANSWER CONSUMER, PHYSICIAN
 QUESTIONS ABOUT OTC ALLERGY MEDICATIONS
 MORRIS PLAINS, N.J., July 8 /PRNewswire/ -- Warner-Lambert (NYSE: WLA) today released the following statement:
 "Allergy patients who may be confused or concerned about their continued use of antihistamines following yesterday's news about FDA restrictions on another company's antihistamine product can have some of their questions answered by a Warner-Lambert medical professional by calling a toll-free hotline.
 "Benadryl, the leading OTC allergy brand, was not affected by the FDA announcement, and continues to be an appropriate choice for people wishing to treat their allergy symptoms. Benadryl is backed by over 45 years of patient experience. We want to reassure the public that they can continue to choose Benadryl for their allergy symptoms.
 "Warner-Lambert remains committed to serving the needs of allergy patients and offers this toll-free hotline number, 1-800-524-2624, to help keep the public informed."
 Warner-Lambert is a worldwide company devoted to developing, manufacturing and marketing quality health care and consumer products. It employs approximately 34,000 people.
 -0- 7/8/92
 /CONTACT: Nancy Fitzsimmons of Warner-Lambert, 201-540-2145/
 (WLA) CO: Warner-Lambert Company ST: New Jersey IN: MTC SU:


LR -- NY071 -- 7607 07/08/92 17:26 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 8, 1992
Words:199
Previous Article:CHAIRMAN AND CEO OF McDONNELL DOUGLAS SENDS LETTER TO PRESIDENT BUSH
Next Article:INTERVOICE ANNOUNCES FISCAL 1993 FIRST QUARTER SALES AND EARNINGS
Topics:


Related Articles
PARKE-DAVIS OFFERS SINGLE AGENT COMMITMENT PROGRAM FOR NEW HYPERTENSION THERAPY
NEW HOTLINE OFFERS FRIENDS A CHANCE TO SEND ENCOURAGING 'WAKE UP' CALLS TO SMOKERS; CALLS PLACED ON THE DAY OF THE GREAT AMERICAN SMOKEOUT
MARION MERRELL DOW POLLEN HOTLINE AVAILABLE NATIONWIDE
WARNER-LAMBERT ANNOUNCES GLOBAL PARTNERSHIP WITH WELLCOME P.L.C.
WARNER-LAMBERT, WELLCOME AND GLAXO ANNOUNCE STRATEGIC ALLIANCES
WARNER-LAMBERT, GLAXO ANNOUNCE CONTRACT-SIGNING FOR OTC MARKETING
WARNER-LAMBERT, WELLCOME ENTER OTC JOINT VENTURE
WARNER-LAMBERT; WELLCOME ENTER OTC JOINT VENTURE
WARNER-LAMBERT TO PURCHASE GLAXO WELLCOME'S INTEREST IN WARNER WELLCOME OTC JOINT VENTURE FOR $1.05 BILLION
WARNER-LAMBERT PURCHASES GLAXO WELLCOME'S INTEREST IN WARNER WELLCOME OTC JOINT VENTURE

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters